2022-08-04至2022-08-05 上海
导航

已确认嘉宾Confirmed Guests

戴朝辉 COO

怀越生物

NK 细胞免疫治疗开发策略及进展

戴朝辉 COO

演讲题目:NK 细胞免疫治疗开发策略及进展

怀越生物

Uni-Mannheim, UNC,上海医科大学;

曾任职于世界五百强医药企业先灵葆雅、德国技术合作公司(GTZ)、Praxair、复星医药集团、尚华医药集团等国内外大型药企,先后担任EVP、Project VP、R&D Director、Project Director等职务。

拥有20多年医药专业及行业管理经验,具有不同机构管理运营、研发、临床管理、投融资、市场&商业化等全流程药品开发经验。近几年重点主持、参与数个生物大分子抗体及细胞治疗项目开发,并申请了多项国内和国际专利。

Graduate from Uni-Mannheim, UNC, Shanghai Medical University.

20 + years of experience in the pharmaceutical industry, worked in MNC, Schering-Plough China, Praxair Asia, Fosun Pharma Group; Joined Shang Pharma as BD head, VP.

Drug development experience in the field of R&D, clinical trial management and market & commercial process; as well as the operational management, BD and investment and financing.

Led and participant a number of antibodies and cell therapy development, 10+patents of international (PCT) and domestic (China).


邀请函

下载邀请函
×
留下姓名电话和邮箱,邀请函直接发送到邮箱
*姓名:
* 电话:
* Email: